---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Pill Identifier by Drugs.com"
developer_entity: "Drugs.com"
bundle_id: "com.drugs.pillidlite"
app_store_id: "398305495"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: true
market_region: "US"
platforms: "iOS"
app_last_updated: "2026-04-09"
report_date: "2026-07-30"
last_verified: "2026-07-30T00:00:00.000Z"
report_version: "2.158"
total_reviews: 142
overall_rating: 3.4
sentiment: "Frustrated"
sentiment_score: 25
confidence: "high"
confidence_score: 0.75
top_praise_theme: "Medical professionals find the pill identification database useful for verifying medication accuracy during clinical shifts"
top_complaint_theme: "Incomplete pill database fails to identify common medications, leading users to label the app as useless"
review_sample_size: 55
total_review_count: 55
analyzed_review_count: 55
data_age_days: 17
momentum_velocity: "maintenance"
intelligence_version: 6
nemesis: "GoodRx: Prescription Savings"
competitor_count: 6
tags: ["medical", "paid", "frustrated sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals", "consumers"]
canonical_url: "https://marlvel.ai/apps/com-drugs-pillidlite"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Pill Identifier by Drugs.com Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Paid
- **Signal**: Rating 3.44 · Sentiment Frustrated
- **Recent focus**: Incomplete pill database fails to identify common medications, leading users to label the app as useless (top complaint) · Medical professionals find the pill identification database useful for verifying medication accuracy during clinical shifts (top praise)

> **TL;DR:** Pill Identifier by Drugs.com is a medical app by Drugs.com, rated 3.44/5 by 142 users, with Frustrated user sentiment (25/100), available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Pill Identifier by Drugs.com faces Frustrated user sentiment (3.44/5 from 142 reviews), with users reporting incomplete pill database fails to identify common medications, leading users to label the app as useless as the primary concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 3.44/5 (142 reviews) |
| **User Mood** | Frustrated |
| **Category** | Medical |
| **Developer** | Drugs.com |
| **Pricing** | Paid |
| **Platforms** | iOS |
| **Confidence** | High (0.75/1.0) |
| **Data Age** | 17d |

## Metadata & Market Performance
- **Publisher:** Drugs.com
- **Category:** Medical
- **Target Audience:** Healthcare professionals and consumers requiring reliable, offline-capable drug identification and clinical information.
- **Platforms:** iOS
- **Version Reviewed:** 2.158
- **Report Date:** 2026-07-30
- **Signal Count:** 55 reviews analyzed
- **Confidence:** High (0.75/1.0)
- **App Store ID (iOS):** 398305495
- **Bundle ID:** com.drugs.pillidlite
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-07-30

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Pill Identifier by Drugs.com is a searchable medication database for healthcare professionals and patients on iOS, featuring offline image access via a paid Pro edition.
**Why users hire it:** The app removes the dependency on constant internet connectivity for clinical medication verification, a critical friction point for medical staff during hospital shifts.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Pill Identifier Search:** Database search by imprint, drug name, shape, and color for over 24,000 medications
  * *User Intent:* Users want to quickly find relevant content or features.
- **[Differentiator] Pro Edition Image Library:** Local installation of over 10,000 pill images for offline access
  * *User Intent:* Users want uninterrupted access without internet dependency.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Pill Identifier currently holds the #26 Paid position in the US Medical category, but its grossing rank at #167 signals limited monetization depth. The reliance on a one-time $0.99 purchase model fails to capture the recurring value seen in adherence-focused rivals.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** Pro edition at $0.99 one-time purchase
- **Price:** iOS: $0.99
- **Analysis:** Paid model anchored at $0.99, gating offline image access and advanced clinical metadata for professional users.

<!-- section:sentiment -->
## 🔴 User Sentiment (High Confidence: 55 of 55 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 3.44/5
- **Platform Split:** iOS 3.4/5 (142 ratings)
- **Overall Sentiment:** Frustrated

### Top Praises
- **Medical professionals find the pill identification database useful for verifying medication accuracy during clinical shifts**

### Top Complaints (Impact Areas)

- **Incomplete pill database fails to identify common medications, leading users to label the app as useless**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Brand authority as a peer-reviewed medical data source

**Growth Levers:**
- Integration of visual photo-based identification to improve search accuracy


<!-- /section:swot -->
## Recent Changes (v5 → v6) {#recent-changes}

The app's competitive standing has deteriorated following the emergence of user reports alleging deceptive billing and persistent, unresolved database failures. These accusations of wrongdoing, combined with a lack of feature development, have intensified the negative sentiment surrounding the product.

**Overall trend**: Declining
**Compared at**: 2026-07-30

### High-impact changes
- **[Declined] Emergence of Deceptive Billing Allegations** (sentiment)

### Medium-impact changes
- **[Added] Specific Generic Drug Identification Failure** (swot)
- **[Removed] Removal of Medication Adherence Gaps** (features)

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Pill Identifier by Drugs.com vs GoodRx: Prescription Savings - Top Rival
- **[GoodRx: Prescription Savings](https://marlvel.ai/apps/com-goodrx-iphone)** by GoodRx: Dominates the medication savings niche with high-velocity updates and a massive, active user base.
  - **Key differences:**
    - Integrates real-time pharmacy pricing and coupons to drive immediate cost-saving transactions for users
    - Maintains a high-frequency release cadence of 13 updates in six months to optimize conversion funnels
    - Leverages a massive pharmacy network integration that creates a significant barrier to entry for competitors

### Contenders (Strong Challengers)
- **[Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe)** by MediSafe Inc.: Focuses on medication adherence and tracking, serving as the primary alternative for long-term health management.
  - Provides complex medication scheduling and refill reminders that go beyond simple pill identification features
  - Users report the app's notification system effectively reduces missed doses through persistent, customizable alerts

### Peers (What They Do Better)
- **[Doximity](https://marlvel.ai/apps/com-doximity-directoryv10)** by Doximity: Operates as a professional medical network, providing clinical utility that overlaps with drug information needs.
  - Functions as a closed professional network for verified clinicians rather than a consumer-facing pill identifier
  - Includes secure communication tools and clinical news feeds that drive high professional retention rates
- **[Express Scripts](https://marlvel.ai/apps/com-medco-medcopharmacy)** by Express Scripts: Provides direct pharmacy benefit management services, capturing users at the point of prescription fulfillment.
  - Enables direct home delivery and prescription management within the app's closed pharmacy ecosystem
  - Some users allege the app's interface prioritizes internal pharmacy services over broader drug information transparency
- **[mySugr - Diabetes Tracker Log](https://marlvel.ai/apps/com-mysugr-companion-mysugr)** by mySugr GmbH: Targets a specific chronic condition, offering specialized tracking that competes for the user's daily attention.
  - Integrates blood glucose logging and data visualization specifically tailored for diabetic patient needs
  - Gamifies the health tracking experience to improve long-term adherence compared to static database apps
- **[OptumRx](https://marlvel.ai/apps/com-optumhealth-mobile-optumrx)** by Optum Inc.: Acts as a pharmacy benefit manager app, focusing on insurance-linked medication management and pricing.
  - Links directly to insurance coverage data to provide personalized out-of-pocket cost estimates for members
  - Users report the app's primary value is managing refills through an insurance-integrated portal

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New

- **Latest (v2.134, 3 years ago):** Updated the medication data and pill imprint library.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Ships periodic medication library updates.
- No new features in recent builds.

> **Cadence:** 10 total versions · 0 majors in last 6 months · 111 days since last update · 51 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Pill Identifier by Drugs.com is a medical app that is a paid app.
With a 3.44/5 rating from 142 reviews, it faces significant user friction.

<!-- speakable-start -->
> **Bottom Line:** The current database coverage gap invalidates the app's core value proposition for many users. Expanding the medication library and introducing visual identification would address the primary churn drivers, shifting the product from a static reference tool to a reliable clinical utility.
<!-- speakable-end -->

**Best for:** Healthcare professionals and consumers requiring reliable, offline-capable drug identification and clinical information.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Ship visual photo-based identification because it is the top-requested feature → improve search accuracy
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors


- Real-time pharmacy pricing and coupons (available in GoodRx but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

Users report: The medication identification market is consolidating around dynamic, service-integrated apps that offer more than just static data. Pill Identifier's maintenance-mode posture leaves it exposed to free web alternatives and high-velocity rivals, necessitating a shift toward visual recognition to remain relevant.

- 🔴 The database coverage gap (frequent 'no result' errors) erodes trust, which compounds the negative sentiment already visible in the latest reviews.
- 🔴 Maintenance-mode release cadence leaves the app vulnerable to rivals with high-frequency updates, accelerating the loss of professional users to more dynamic platforms.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 3.44/5 |
| Total Reviews | 142 |
| Sentiment | Frustrated (25/100) |
| Confidence | High |
| Pricing Model | Paid |
| Platforms | iOS |
| Key Features | 2 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Pill Identifier by Drugs.com** (this app) | 3.44/5 | Frustrated | Drugs.com |
| [Express Scripts](https://marlvel.ai/apps/com-medco-medcopharmacy) | 4.7/5 | Mixed | Express Scripts |
| [GoodRx: Prescription Savings](https://marlvel.ai/apps/com-goodrx-iphone) | 4.8/5 | Thrilled | GoodRx |
| [Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe) | 4.7/5 | n/a | MediSafe Inc. |
| [Doximity](https://marlvel.ai/apps/com-doximity-directoryv10) | 4.8/5 | Excited | Doximity |
| [OptumRx](https://marlvel.ai/apps/com-optumhealth-mobile-optumrx) | 4.7/5 | N/A | Optum Inc. |

## Company Profile
- **Developer:** Drugs.com
- **Website:** [https://www.drugs.com/apps/](https://www.drugs.com/apps/)
- **Social:** [Instagram](https://www.instagram.com/drugs.com_official) · [Facebook](https://www.facebook.com/Drugscom) · [X/Twitter](https://twitter.com/drugscom) · [YouTube](https://www.youtube.com/user/drugscom)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/pill-identifier-by-drugs-com/id398305495?uo=2)
- **Dev Site:** [Official Website](https://www.drugs.com/apps/)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*Express Scripts*](https://marlvel.ai/apps/com-medco-medcopharmacy) (Express Scripts) · 4.7/5 Rating
- [*GoodRx: Prescription Savings*](https://marlvel.ai/apps/com-goodrx-iphone) (GoodRx) · 4.8/5 Rating | Excellent Sentiment
- [*Medisafe Medication Management*](https://marlvel.ai/apps/com-medisafe-medisafe) (MediSafe Inc.) · 4.7/5 Rating
- [*Doximity*](https://marlvel.ai/apps/com-doximity-directoryv10) (Doximity) · 4.8/5 Rating | Positive Sentiment
- [*OptumRx*](https://marlvel.ai/apps/com-optumhealth-mobile-optumrx) (Optum Inc.) · 4.7/5 Rating
- [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/apps/com-mysugr-companion-mysugr) (mySugr GmbH) · 4.7/5 Rating
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.75/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 55
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 17 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-drugs-pillidlite)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.